浏览全部资源
扫码关注微信
1.内蒙古医科大学蒙医药学院(内蒙古 呼和浩特 010110)
2.内蒙古医科大学药学院(内蒙古 呼和浩特 010110)
3.内蒙古医科大学民族医药创新中心(内蒙古 呼和浩特 010110)
Published:25 May 2024,
Received:08 September 2022,
Revised:26 March 2024,
扫 描 看 全 文
,,戴 ,丽.蒙药材香青兰的质量标准研究[J].上海中医药大学学报,2024,38(03):27-34.
LIAN hua,HU Rilebagen.Study on quality standards of mongolian medicine Dracocephalum moldavica[J].Academic Journal of Shanghai University of Traditional Chinese Medicine,2024,38(03):27-34.
,,戴 ,丽.蒙药材香青兰的质量标准研究[J].上海中医药大学学报,2024,38(03):27-34. DOI: 10.16306/j.1008-861x.2024.03.004.
LIAN hua,HU Rilebagen.Study on quality standards of mongolian medicine Dracocephalum moldavica[J].Academic Journal of Shanghai University of Traditional Chinese Medicine,2024,38(03):27-34. DOI: 10.16306/j.1008-861x.2024.03.004.
目的
2
建立内蒙古不同地区香青兰质量标准,为该药材质量控制提供实验依据。
方法
2
夏季盛花期采集内蒙古不同地区香青兰,阴干;建立香青兰的性状、显微特征、薄层色谱(TLC)鉴别方法,以及迷迭香酸含量的高效液相色谱(HPLC)测定方法;按照《中华人民共和国药典(2020年版)》通则中的相关方法,对香青兰药材的水分、总灰分、酸不溶性灰分及浸出物等进行测定。
结果
2
香青兰的性状、显微特征、TLC等均有明显的专属特征,水分为6.20%~8.42%,总灰分为6.79%~12.11%,酸不溶性灰分为0.71%~4.28%,热浸法水溶性浸出物为23.45%~35.85%,冷浸法水溶性浸出物为15.61%~32.74%。迷迭香酸浓度在0.30~1.80 mg/L(
r
=0.999 8)范围内呈良好线性关系,平均加样回收率为97.89%,
RSD
为(0.25~1.68)%。9批香青兰药材样品中迷迭香酸含量在0.94~7.25 mg/g,平均含量为4.27 mg/g。
结论
2
所建立的香青兰含量测定方法简便、准确、重复性好,能有效评价香青兰的质量,以保障其蒙医临床应用的有效性。
Objective: To establish the quality standard of
Dracocephalum moldavica
in different areas of Inner Mongolia, and to provide experimental basis for the quality control of this herb.
Methods
2
Dracocephalum moldavica
were collected from different areas of Inner Mongolia during the summer blooming period, dried. The morphological features, microscopic features, thin-layer chromatography (TLC) identification methods of
Dracocephalum moldavica,
and high performance liquid chromatography (HPLC) method for the determination of rosmarinic acid content were established. According to the relevant methods in the general rules of
Pharmacopoeia of the People's Republic of China (2020 Edition)
, the moisture, total ash, acid-insoluble ash and extracts content of
Dracocephalum moldavica
were determined.
Results
2
The characteristics, microscopic characteristics and TLC of
Dracocephalum moldavica
had obvious exclusive characteristics. The moisture content was 6.20%~8.42%. The total ash content was 6.79%~12.11%. The acid-insoluble ash content was 0.71%~4.28%. The water-soluble extracts content by hot immersion method was 23.45%~35.85%, an
d the water-soluble extracts content by cold immersion method was 15.61%~32.74%. The concentration of rosmarinic acid showed a good linear relationship in the range of 0.30~1.80 mg/L (
r
=0.999 8). The average recovery rate was 97.89% and the
RSD
was (0.25~1.68)%. The content of rosmarinic acid in 9 batches of
Dracocephalum moldavica
samples ranged from 0.94 to 7.25 mg/g, with an average content of 4.27 mg/g.
Conclusion
2
The established method is simple, accurate and reproducible, and can effectively evaluate the quality of
Dracocephalum moldavica
, so as to ensure its effectiveness of clinical application in Mongolian medicine.
香青兰蒙药材迷迭香酸显微鉴别薄层色谱高效液相色谱质量标准
Dracocephalum moldavicaMongolian medicinal materialrosmarinic acidmicroscopic identificationthin-layer chromatographyhigh performance liquid chromatographyquality standard
伊希巴拉珠尔. 甘露四部[M].呼和浩特:内蒙古人民出版社,1998: 544.
YI X B L Z E. The Four Tantras of Nectar[M]. Hohhot: Inner Mongolia People's Publishing House, 1998: 544.
策苏荣扎布. 蒙古学百科全书[M]. 呼和浩特:内蒙古人民出版社, 2012: 7.
CE S R Z B. Encyclopedia of Mongolian Studies[M]. Hohhot:Inner Mongolia People's Publishing House, 2012: 7.
占布拉道尔吉. 无误蒙药鉴[M]. 赤峰:内蒙古科学技术出版社,1988:254.
ZHAN B L D E J. Wuwumengyaojian[M]. Chifeng:Inner Mongolia Science and Technology Press, 1988: 254.
内蒙古自治区卫生厅. 内蒙古蒙药材标准[M]. 赤峰:内蒙古科学技术出版社, 1987: 456.
Inner Mongolia Autonomous Region health Department. Inner Mongolia Standard for Mongolian medicinal materials[M]. Chifeng: Inner Mongolia Science and Technology Press, 1987: 456.
马毓泉. 内蒙古植物志(第一版):第五卷[M]. 呼和浩特:内蒙古人民出版社, 1980: 191.
MA Y Q. Flora intramongolica(First Edition):Volume 5[M]. Hohhot:Inner Mongolia People's Publishing House, 1980: 191.
奇玲,罗达尚. 中国少数民族传统医药大系[M]. 赤峰:内蒙古科学技术出版社, 2000: 326-397.
QI L,LUO D S. Chinese minority traditional medicine department[M]. Chifeng:InnerMongolia Science and Technology Press, 2000:326-397.
孙慧珠,刘晓明,徐乐,等. 杜仲降压片质量标准的提高与优化[J]. 药物分析杂志, 2020, 40(8): 1514-1520.
SUN H Z,LIU X M,XU L,et al. Study on the quality standard of Duzhong jiangya tablets[J]. Chinese Journal of Pharmaceutical Analysis, 2020, 40(8): 1514-1520.
阿迪拉木•阿比利米提,王新玲,热娜•卡斯木,等. 香青兰抗血小板聚集及抗血栓作用[J]. 中药药理与临床, 2013, 29(6):86-89.
ADILAMU A B L M T,WANG X L,RENA K S M,et al. Study on anti-platelet aggregation and anti-thrombotic role of Dracocephalum moldavica L[J]. Pharmacology and Clinics of Chinese Materia Medica, 2013, 29(6): 86-89.
ZHANG Y J, XU W Q, SHEN X, et al. New progress in the research of rosmarinic acid separation, purification and pharmacological actions[J]. Chin J Ne Drugs, 2013, 22(4): 433-437.
国家药典委员会. 中华人民共和国药典(2020年版):四部[M]. 北京:中国医药科技出版社, 2020: 234.
Chinese Pharmacopoeia Commission. Pharmacopoeia of People's Republic of China(2020 Edition): Part IV[M]. Beijing:China Medical Science Press, 2020: 234.
中华人民共和国卫生部药典委员会. 中华人民共和国卫生部药品标准(蒙药分册)[M]. 呼和浩特:内蒙古人民出版社,1998: 156.
Chinese Pharmacopoeia Commission. Ministry of Health of the People's Republic of China Drug Standards (Mongolian Medicine Volume)[M]. Hohhot:Inner Mongolia People's Publishing House, 1998: 156.
内蒙古自治区食品药品监督管理局. 内蒙古蒙药材标准(增补本)(2015年版)[M]. 呼和浩特:内蒙古人民出版社, 2018.
Food and Drug Administration of Inner Mongolia Autonomous Region. Inner Mongolia Standard for Mongolian Medicinal Materials(enlarged text)(2015 Edition)[M]. Hohhot:Inner Mongolia People's Publishing House, 2018.
内蒙古自治区食品药品监督管理局.内蒙古蒙药炮制规范(2015年版)[M]呼和浩特:内蒙古人民出版社, 2016.
Food and Drug Administration of Inner Mongolia Autonomous Region. Mongolian Medicine Processing Standards of Inner Mongolia(2015 Edition)[M]. Hohhot: Inner Mongolia People's Publishing House, 2016.
内蒙古自治区食品药品监督管理局.内蒙古蒙药材炮制规范(2017年增补版)[M]北京:中国医药科技出版社, 2018.
Food and Drug Administration of Inner Mongolia Autonomous Region. Inner Mongolia Mongolian Medicine Processing Standards(Updated in 2017)[M]. Beijing:China Medical Science Press,2018.
内蒙古植物药志编辑委员会. 内蒙古植物药志(第二版)[M]. 呼和浩特:内蒙古人民出版社, 1980: 442-444.
Inner Mongolia Botanical and medicinal annals Editorial Committee. Flora and Pharmacology of Inner Mongolia(Second Edition)[M]. Hohhot:Inner Mongolia People's Publishing House, 1980: 442-444.
国家中医药管理局. 中华本草(蒙药卷)[M]. 上海:上海科学技术出版社, 2004: 306.
National Administration of Traditional Chinese Medicine. Chinese Materia Medica(Roller of Mongolian Medicine)[M]. Shanghai Scientific and Technical Publishers, 2004: 306.
内蒙古自治区卫生厅. 内蒙古蒙药材标准[M]. 赤峰:内蒙古科学技术出版社, 1986: 456.
Inner Mongolia Autonomous Region health Department. Inner Mongolia Standard for Mongolian Medicinal Materials[M]. Chifeng: Inner Mongolia Science and Technology Press,1986: 456.
内蒙古自治区食品药品监督管理局.内蒙古蒙药饮片炮制规范(2020年版)[M]. 呼和浩特:内蒙古人民出版社, 2020: 202.
Food and Drug Administration of Inner Mongolia Autonomous Region. InnerMongolia Mongolian medicine decoction piece processing standards[M]. Hohhot:Inner Mongolia People's Publishing House, 2020: 202.
EHSANI A, ALIZADEH O, HASHEMI M, et al. Phytochemical,antioxidant and antibacterial properties of Melissa officinalis and Dracocephalum moldavica essential oils[J]. Vet Res Forum,2017, 8(3): 223-229.
CAO W, HU N, YUAN Y, et al. Effects of Tilianin on Proliferation, Migration and TGF-β/Smad Signaling in Rat Vascular Smooth Muscle Cells Induced with Angiotensin Ⅱ[J]. Phytother Res, 2017, 31(8): 1240-1248.
ZENG C, JIANG W, YANG X, et al. Pretreatment with Total Flavonoid Extract from Dracocephalum Moldavica L. Attenuates Ischemia Reperfusion-induced Apoptosis[J]. Sci Rep, 2018, 8(1):17491.
MAIMAITIYIMING D, HU G, AIKEMU A, et al. The treatment of Uygur medicine Dracocephalum moldavica L on chronic mountain sickness rat model[J]. Pharmacogn Mag, 2014, 10(40):477-482.
MARTÍNEZ-VÁZQUEZ M, ESTRADA-REYES R, MARTÍNEZ-LAURRABAQUIO A, et al. Neuropharmacological study of Dracocephalum moldavica L. (Lamiaceae) in mice: sedative effect and chemical analysis of an aqueous extract[J]. J Ethnopharmacol, 2012, 141(3): 908-917.
何承辉,康小龙,邢建国,等. 香青兰总黄酮对哮喘大鼠白三烯B4、C4、C反应蛋白和白介素-10表达的影响[J]. 中华中医药杂志,2014, 29(2): 615-617.
HE C H,KANG X L, XING J G, et al. Effects of moldavica total flavone on leukotriene B4, leukotriene C4, C reactive protein and interleukin-10 levels in asthma rats[J]. China Journal of Traditional Chinese Medicine and Pharmacy, 2014, 29(2): 615-617.
闫丽丽,康小龙,何承辉,等. 香青兰总黄酮对支气管哮喘大鼠 Th1 /Th2 免疫失衡的调节作用[J]. 中国医科大学学报,2013, 42(1): 8-13.
YAN L L,KANG X L,HE C H,et al. Effects of Moldavica Total Flavone on Regulation of Th1 /Th2 Imbalance in Ovalbumin-induced Asthmatic Rats[J]. Journal of China Medical University,2013, 42(1): 8-13.
杨彩玉,安希文,付伟,等.香青兰总黄酮对大鼠离体胸主动脉的舒张作用[J].生物物理学报, 2010, 26(4): 334 -340.
YANG C Y,AN X W, FU W, et al. Vasodilative Effect of Dracocephalum moldavica L. Total Flavonoids in Isolated Rat Aortic Rings[J]. Acta Biophysica Sinica, 2010, 26(4): 334 -340.
洪叶.香青兰总黄酮对大鼠心肌缺血再灌注损伤诱导的自噬作用的研究[J].中国药学杂志, 2016, 51(11): 890-895.
HONG Y. Effect of Dracocephalum Total Flavonoids on Myocardial Ischemia/Reperfusion-Induced Autophagy in Rats[J]. Chinese Pharmaceutical Journal, 2016, 51(11): 890-895.
王盛,邢建国,王新春,等. 香青兰总黄酮抗心肌细胞缺氧/复氧损伤作用的研究[J]. 石河子大学学报(自然科学版), 2014, 32(5): 568-572.
WANG S,XING J G,WANG X C,et al.Protective Effects of Dracocephalum moldavica L. Flavonoids on Cultured Cardiomyocytes in Vitro Hypoxia/Reoxygenation[J]. Journal of Shihezi University (Natural Science), 2014, 32(5): 568-572.
SHEN W, ANWAIER G, CAO Y, et al. Atheroprotective Mechanisms of Tilianin by Inhibiting Inflammation Through Down-Regulating NF‑κB Pathway and Foam Cells Formation[J]. Front Physiol, 2019, 10: 825.
JIA J X,ZHANG Y,WANG Z L,et al.The inhibitory effects of Dracocephalum moldavica L.(DML)on rat cerebral ischemia reperfusion injury[J]. J Toxicol Environ Health A, 2017, 9: 1206-1211.
ZHANG H, XU L,LIU X,et al.Dracomolphesin A-E, five 3,4-seco-phenylpropanoids with Nrf2 inducing activity from Dracocephalum moldavica[J].Chin Chem Lett, 2020, 31(5):1259-1262.
李琼,冯长根. 香青兰降血脂化学成分实验研究[J]. 中成药,2004, 26(11): 947-948.
LI Q,FENG C G. Experimental study on hypolipidemic chemical constituents of Pandan [J].Chinese Traditional Patent Medicine,2004, 26(11): 947-948.
哈丽娅•吐尔逊麦麦提,米热阿依•亚力昆,热娜古丽•艾则孜,等. 高效液相色谱法测定破布木果水提物中迷迭香酸的含量[J].食品安全质量检测学报, 2020, 11(4): 1215-1219.
HALIYA T E X M M T, MIREAYI Y L K,RENAGULI A Z Z, et al. Determination of rosmarinic acid in water extract of Cordia dichotoma fruits by high performanceliquid chromatography[J]. Journal of Food Safety & Quality, 2020, 11(4): 1215-1219.
JIANG J, YUAN X, WANG T, et al. Antioxidative and Cardioprotective Effects of Total Flavonoids Extracted from Dracocephalum moldavica, L. Against Acute Ischemia Reperfusion-Induced Myocardial Injury in Isolated Rat Heart[J].Cardiovascular Toxicology, 2014, 14(1): 74-82.
孙慧珠,刘晓明,徐乐,等.杜仲降压片质量标准的提高与优化[J].药物分析杂志, 2020, 40(8): 1514-1520.
SUN H Z,LIU X M,XU L,et al.Study on the quality standard of Duzhong Jiangya tablets[J]. Chinese Journal of Pharmaceutical Analysis, 2020, 40(8): 1514-1520.
鲁芹飞,唐海明,陈玲玲,等.狭基线纹香茶菜(溪黄草)咖啡酸和迷迭香酸的薄层鉴别与含量测定[J].中国实验方剂学杂志, 2023, 19(22): 114-116.
LU Q F, TANG H M, CHEN L L, et al. Identification and Determination of Caffeic Acid and Rosmarinic Acid in Rabdosia lophanthoides var gerardiana by TLC and HPLC[J]. Chinese Journal of Experimental Traditional Medical Formulae, 2023, 19(22): 114-116.
迟玉霞,肖海燕,胡冬梅,等. HPLC法测定解毒散结丸中迷迭香酸含量方法的研究[J].山东化工, 2022, 51(18): 137-140.
CHI Y X,XIAO H Y ,HU D M,et al.Determination of Rosmarinic Acid in Detoxification Dissipate Pills by HPLC[J]. Shandong Chemical Industry, 2022, 51(18): 137-140.
何凤,严建良,吴孔松,等. HPLC法测定肠炎宁颗粒中芦丁、迷迭香酸的含量[J]. 海峡药学, 2022, 34(3): 86-89.
HE F,YAN J L,WU K S,et al.Determination of Ruin and Rosmarinic Acid in Changyanning Granules by HPLC[J]. Strait Pharmaceutical Journal, 2022, 34(3): 86-89.
0
Views
0
下载量
0
CSCD
0
CNKI被引量
Publicity Resources
Related Articles
Related Author
Related Institution